Second Sight Reports Second Quarter 2017 Financial Results
SYLMAR, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide useful vision to blind patients, today reported financial results for the three- and six-month periods ended June 30, 2017. Recent Company Highlights: Generated net sales of $2.2 million in the second quarter of 2017 compared to $1.0 million in the second quarter of 2016; Increased implant volum